Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment

Miguel Sogbe, Idoia Bilbao, Francesco P. Marchese, Jon Zazpe, Annarosaria De Vito, Marta Pozuelo, Delia D’Avola, Mercedes Iñarrairaegui, Carmen Berasain, Maria Arechederra, Josepmaria Argemi, Bruno Sangro

Clin Mol Hepatol. 2024;30(2):177-190. Published online December 29, 2023

DOI: https://doi.org/10.3350/cmh.2023.0426

View: 5442 Download: 194 Crossref: 1

Review

Recent advances in the management of hepatocellular carcinoma

Kamya Sankar, Jun Gong, Arsen Osipov, Steven A. Miles, Kambiz Kosari, Nicholas N. Nissen, Andrew E. Hendifar, Ekaterina K. Koltsova, Ju Dong Yang

Clin Mol Hepatol. 2024;30(1):1-15. Published online July 21, 2023

DOI: https://doi.org/10.3350/cmh.2023.0125

View: 5342 Download: 277 Web of Science: 2 Crossref: 4

Hepatocellular carcinoma surveillance in patients with non-alcoholic fatty liver disease

Karim Seif El Dahan, Darine Daher, Amit G. Singal

Clin Mol Hepatol. 2023;29(Suppl):S207-S219. Published online September 14, 2022

DOI: https://doi.org/10.3350/cmh.2022.0247

View: 7029 Download: 160 Web of Science: 4 Crossref: 6

Non-invasive biomarkers for liver inflammation in non-alcoholic fatty liver disease: present and future

Terry Cheuk-Fung Yip, Fei Lyu, Huapeng Lin, Guanlin Li, Pong-Chi Yuen, Vincent Wai-Sun Wong, Grace Lai-Hung Wong

Clin Mol Hepatol. 2023;29(Suppl):S171-S183. Published online December 12, 2022

DOI: https://doi.org/10.3350/cmh.2022.0426

View: 4274 Download: 259 Web of Science: 5 Crossref: 5

Correspondence

Correspondence on Letter 1 regarding “Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma”

Yee Hui Yeo, Jamil S. Samaan, Wee Han Ng

Clin Mol Hepatol. 2023;29(3):821-822. Published online May 31, 2023

DOI: https://doi.org/10.3350/cmh.2023.0183

View: 2074 Download: 67 Web of Science: 1 Crossref: 1

Snapshot

Systemic therapy in advanced hepatocellular carcinoma

Joseph C. Ahn, Nguyen H. Tran, Ju Dong Yang

Clin Mol Hepatol. 2023;29(2):516-519. Published online February 20, 2023

DOI: https://doi.org/10.3350/cmh.2023.0051

View: 3293 Download: 158 Web of Science: 3 Crossref: 3

Original Article

Factors associated with unrecognized cirrhosis in patients with hepatocellular carcinoma

Yi-Te Lee, Mohammad A. Karim, Hye Chung Kum, Sulki Park, Nicole E. Rich, Mazen Noureddin, Amit G. Singal, Ju Dong Yang

Clin Mol Hepatol. 2023;29(2):453-464. Published online February 1, 2023

DOI: https://doi.org/10.3350/cmh.2022.0450

View: 3288 Download: 114 Web of Science: 2 Crossref: 2

Global burden of primary liver cancer and its association with underlying aetiologies, sociodemographic status, and sex differences from 1990–2019: A DALY-based analysis of the Global Burden of Disease 2019 study

Sungchul Choi, Beom Kyung Kim, Dong Keon Yon, Seung Won Lee, Han Gyeol Lee, Ho Hyeok Chang, Seoyeon Park, Ai Koyanagi, Louis Jacob, Elena Dragioti, Joaquim Radua, Jae Il Shin, Seung Up Kim, Lee Smith

Clin Mol Hepatol. 2023;29(2):433-452. Published online January 4, 2023

DOI: https://doi.org/10.3350/cmh.2022.0316

View: 5196 Download: 226 Web of Science: 12 Crossref: 13

Review

Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Taiwan perspective

Tung-Hung Su, Chih-Horng Wu, Tsung-Hao Liu, Cheng-Maw Ho, Chun-Jen Liu

Clin Mol Hepatol. 2023;29(2):230-241. Published online January 30, 2023

DOI: https://doi.org/10.3350/cmh.2022.0421

View: 5133 Download: 349 Web of Science: 8 Crossref: 8

Correspondence

Correspondence on Editorial regarding “Impact of nationwide hepatocellular carcinoma surveillance on the prognosis in patients with chronic liver disease”

Won Sohn, Yong-Han Paik

Clin Mol Hepatol. 2023;29(1):182-184. Published online November 22, 2022

DOI: https://doi.org/10.3350/cmh.2022.0411

View: 2662 Download: 40

Editorial

Surveillance for hepatocellular carcinoma: It is time to move forward

Bo Hyun Kim, Yuri Cho, Joong-Won Park

Clin Mol Hepatol. 2022;28(4):810-813. Published online September 6, 2022

DOI: https://doi.org/10.3350/cmh.2022.0257

View: 2767 Download: 88 Web of Science: 5 Crossref: 5

Review

Intrahepatic cholangiocarcinoma: Tumour heterogeneity and its clinical relevance

Mina Komuta

Clin Mol Hepatol. 2022;28(3):396-407. Published online January 14, 2022

DOI: https://doi.org/10.3350/cmh.2021.0287

View: 5614 Download: 338 Web of Science: 14 Crossref: 16

MAFLD enhances clinical practice for liver disease in the Asia-Pacific region

Takumi Kawaguchi, Tsubasa Tsutsumi, Dan Nakano, Mohammed Eslam, Jacob George, Takuji Torimura

Clin Mol Hepatol. 2022;28(2):150-163. Published online November 10, 2021

DOI: https://doi.org/10.3350/cmh.2021.0310

View: 7174 Download: 363 Web of Science: 51 Crossref: 49

Original Article

Direct comparison of biopsy techniques for hepatic malignancies

Shang-Chin Huang, Ja-Der Liang, Shih-Jer Hsu, Tzu-Chan Hong, Hung-Chih Yang, Jia-Horng Kao

Clin Mol Hepatol. 2021;27(2):305-312. Published online December 3, 2020

DOI: https://doi.org/10.3350/cmh.2020.0301

View: 4667 Download: 159 Web of Science: 10 Crossref: 11

Obesity and the risk of primary liver cancer: A systematic review and meta-analysis

Won Sohn, Hyun Woong Lee, Sangheun Lee, Jin Hong Lim, Min Woo Lee, Chan Hyuk Park, Seung Kew Yoon

Clin Mol Hepatol. 2021;27(1):157-174. Published online November 26, 2020

DOI: https://doi.org/10.3350/cmh.2020.0176

View: 9146 Download: 389 Web of Science: 68 Crossref: 74

Effectiveness of nivolumab versus regorafenib in hepatocellular carcinoma patients who failed sorafenib treatment

Cheol-Hyung Lee, Yun Bin Lee, Minseok Albert Kim, Heejoon Jang, Hyunwoo Oh, Sun Woong Kim, Eun Ju Cho, Kyung-Hun Lee, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Tae-You Kim, Yoon Jun Kim

Clin Mol Hepatol. 2020;26(3):328-339. Published online May 28, 2020

DOI: https://doi.org/10.3350/cmh.2019.0049n

View: 8328 Download: 336 Web of Science: 30 Crossref: 30

Review

Detect or not to detect very early stage hepatocellular carcinoma? The western perspective

Ju Dong Yang

Clin Mol Hepatol. 2019;25(4):335-343. Published online March 29, 2019

DOI: https://doi.org/10.3350/cmh.2019.0010

View: 10642 Download: 234 Web of Science: 38 Crossref: 38

Original Article

Underlying liver disease and advanced stage liver cancer are associated with elevated neutrophil-lymphocyte ratio

Linda Wong, Kliment Bozhilov, Brenda Hernandez, Sandi Kwee, Owen Chan, Luke Ellis, Loic LeMarchand

Clin Mol Hepatol. 2019;25(3):305-316. Published online April 19, 2019

DOI: https://doi.org/10.3350/cmh.2019.0004

View: 6251 Download: 167 Web of Science: 22 Crossref: 20

Review

Hepatocellular carcinoma surveillance in the 21st century: Saving lives or causing harm?

Ibrahim A. Hanouneh, Naim Alkhouri, Amit G. Singal

Clin Mol Hepatol. 2019;25(3):264-269. Published online March 4, 2019

DOI: https://doi.org/10.3350/cmh.2019.1001

View: 9604 Download: 324 Web of Science: 47 Crossref: 47

Original Article

Association between hepatic steatosis and the development of hepatocellular carcinoma in patients with chronic hepatitis B

Yun Bin Lee, Yeonjung Ha, Young Eun Chon, Mi Na Kim, Joo Ho Lee, Hana Park, Kwang-il Kim, Soo-Hwan Kim, Kyu Sung Rim, Seong Gyu Hwang

Clin Mol Hepatol. 2019;25(1):52-64. Published online October 23, 2018

DOI: https://doi.org/10.3350/cmh.2018.0040

View: 8409 Download: 338 Web of Science: 73 Crossref: 70

Review

Epidemiology of liver cancer in South Korea

Bo Hyun Kim, Joong-Won Park

Clin Mol Hepatol. 2018;24(1):1-9. Published online December 18, 2017

DOI: https://doi.org/10.3350/cmh.2017.0112

View: 14493 Download: 482 Web of Science: 133 Crossref: 136

Original Article

Pitfalls in surveillance for hepatocellular carcinoma: How successful is it in the real world?

Linda L. Wong, Ruel J. Reyes, Sandi A. Kwee, Brenda Y. Hernandez, Sumodh C. Kalathil, Naoky C. Tsai

Clin Mol Hepatol. 2017;23(3):239-248. Published online July 14, 2017

DOI: https://doi.org/10.3350/cmh.2017.0008

View: 7743 Download: 143 Web of Science: 32 Crossref: 34

Review

The mutational landscape of hepatocellular carcinoma

Ju-Seog Lee

Clin Mol Hepatol. 2015;21(3):220-229. Published online September 30, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.3.220

View: 13998 Download: 381 Web of Science: 90 Crossref: 79

Liver Imaging

Pseudocirrhosis as a complication after chemotherapy for hepatic metastasis from breast cancer

Woo Kyoung Jeong, Seo-Youn Choi, Jinoo Kim

Clin Mol Hepatol. 2013;19(2):190-194. Published online June 27, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.2.190

View: 8505 Download: 116 Crossref: 23

Case Report

Severe steatohepatitis with hepatic decompensation resulting from malnutrition after pancreaticoduodenectomy

Eun Hui Sim, Jung Hyun Kwon, Se Young Kim, Seung Min Jung, Lee-So Maeng, Jeong Won Jang, Kyu Won Chung

Clin Mol Hepatol. 2012;18(4):404-410. Published online December 21, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.4.404

View: 7261 Download: 83 Crossref: 13

Original Article

Applicability of the BCLC staging system to patients with hepatocellular carcinoma in Korea: analysis at a single center with a liver transplant center

Sung Eun Kim, Han Chu Lee, Kang Mo Kim, Young-Suk Lim, Young-Hwa Chung, Yung Sang Lee, Dong Jin Suh

Clin Mol Hepatol. 2011;17(2):113-119. Published online June 23, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.2.113

View: 8433 Download: 48 Crossref: 25

3

The relationship between hepatitis B virus infection and the incidence of pancreatic cancer: a retrospective case-control study

Seung Goun Hong, M.D., Ji Hoon Kim, M.D., Young Sun Lee, M.D., Eileen Yoon, M.D., Hyun Jung Lee, M.D., Jin Ki Hwang, M.D., Eun Suk Jung, M.D., Moon Kyung Joo, M.D., Young Kul Jung, M.D., Jong Eun Yeon, M.D., Jong-Jae Park, M.D., Jae Seon Kim, M.D., Young-Tae Bak, M.D., Kwan Soo Byun, M.D.

Clin Mol Hepatol. 2010;16(1):49-56. Published online March 26, 2010

DOI: https://doi.org/10.3350/kjhep.2010.16.1.49

View: 5113 Download: 89 Crossref: 13

2

Recent developments in systemic chemotherapy for hepatocellular carcinoma

Chul Ju Han

Clin Mol Hepatol. 2008;14(1):4-11. Published online March 20, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.1.4

View: 4409 Download: 35 Crossref: 1

The Role of Activated Hepatic Stellate Cells in Liver Fibrosis, Portal Hypertension and Cancer Angiogenesis

June Sung Lee , Jong Hoon Kim

Clin Mol Hepatol. 2007;13(3):309-319. Published online September 20, 2007

DOI: https://doi.org/10.3350/kjhep.2007.13.3.309

View: 5070 Download: 61 Crossref: 12

4

Liver Metastasis of Colon Cancer with a High Serum alpha-Fetoprotein Level: Report of a Case

Min An, M.D., Jeong A Shin, M.D., Sang-Min Lee, M.D., Tak Yoon, M.D. Weon Seo Park, M.D. Joon Il Choi, M.D., and Chang-Min Kim, M.D.

Clin Mol Hepatol. 2006;12(4):562-567. Published online January 1, 1970

View: 2742 Download: 29

1 | 2 |

Viewed By 5442	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5422	MAFLD: How is it different from NAFLD?
Viewed By 5300	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3966	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 3964	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 77	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 68	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 52	MAFLD: How is it different from NAFLD?

Search